BPTH Bio Path Holdings Inc
|
23.26
|
ARDX Ardelyx Inc
|
21.76
|
AVDL Avadel Pharmaceuticals PLC
|
19.55
|
SMMT Summit Therapeutics Inc
|
19.35
|
DRRX DURECT Corp
|
15.86
|
TNXP Tonix Pharmaceuticals Holding Corp
|
15.51
|
CTXR Citius Pharmaceuticals Inc
|
15.44
|
RCEL AVITA Medical Inc
|
15.18
|
SLN Silence Therapeutics PLC
|
14.01
|
VXRT Vaxart Inc
|
12.28
|
VIRX Viracta Therapeutics Inc
|
10.72
|
BMRA Biomerica Inc
|
10.36
|
CPIX Cumberland Pharmaceuticals Inc
|
10.35
|
LYRA Lyra Therapeutics Inc
|
10.26
|
MRNS Marinus Pharmaceuticals Inc
|
10.0
|
NKTR Nektar Therapeutics
|
8.63
|
VVOS Vivos Therapeutics Inc
|
7.3
|
RVPH Reviva Pharmaceuticals Holdings, Inc.
|
6.68
|
GLYC GlycoMimetics Inc
|
5.75
|
CRDL Cardiol Therapeutics Inc
|
5.22
|
ADXN Addex Therapeutics Ltd
|
4.65
|
CSBR Champions Oncology Inc
|
-1.6
|
UNCY Unicycive Therapeutics Inc
|
-3.58
|
FENC Fennec Pharmaceuticals Inc
|
-6.14
|
XERS Xeris Biopharma Holdings Inc
|
-6.19
|
OPTN OptiNose Inc
|
-7.69
|
HRTX Heron Therapeutics Inc
|
-8.6
|
AMRX Amneal Pharmaceuticals Inc
|
-9.84
|
PSTV Plus Therapeutics Inc
|
-9.87
|
JAGX Jaguar Health Inc
|
-10.41
|
DERM Journey Medical Corp
|
-10.87
|
ITRM Iterum Therapeutics PLC
|
-15.44
|
AQST Aquestive Therapeutics Inc
|
-16.22
|
FHTX Foghorn Therapeutics Inc.
|
-16.58
|
AKBA Akebia Therapeutics Inc
|
-18.24
|
VRCA Verrica Pharmaceuticals Inc
|
-24.32
|
RIGL Rigel Pharmaceuticals Inc
|
-27.07
|
GALT Galectin Therapeutics Inc
|
-32.9
|
PYPD PolyPid Ltd
|
-41.3
|
KPTI Karyopharm Therapeutics Inc
|
-41.5
|
NRXP NRX Pharmaceuticals Inc
|
-46.22
|
ESPR Esperion Therapeutics Inc
|
-61.7
|
IRWD Ironwood Pharmaceuticals Inc
|
-64.0
|
BCRX BioCryst Pharmaceuticals Inc
|
-73.68
|
FGEN FibroGen Inc
|
-78.77
|
NERV Minerva Neurosciences Inc
|
-100.95
|
PRFX PainReform Ltd
|
-115.02
|
NOTV Inotiv Inc
|
-243.89
|
NLSP NLS Pharmaceutics AG
|
-306.28
|
CAH 卡地納健康
|
-441.09
|
PTCT PTC Therapeutics Inc
|
-446.3
|
QLGN Qualigen Therapeutics Inc
|
-638.95
|
LH Labcorp Holdings Inc
|
-721.11
|
COLL Collegium Pharmaceutical Inc
|
-867.73
|